½ÃÀ庸°í¼­
»óǰÄÚµå
1518487

ÃÊÀ½ÆÄ ÇÁ·Îºê ½ÃÀå ±Ô¸ð : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ¿¹Ãø(2024-2032³â)

Ultrasound Probes Market Size - By Product (Probe, Accessories, Software & Service), Application (Musculoskeletal, Oncology, Cardiovascular, General Imaging, Obstetrics & Gynecology), End-use (Hospital, Clinic, Diagnostic Center) & Forecast 2024 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 196 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÃÊÀ½ÆÄ ÇÁ·Îºê ½ÃÀåÀº Áö¼ÓÀû ±â¼ú Çõ½Å°ú ÷´Ü Á¦Ç° ÅõÀÔ¿¡ ÀÇÇØ 2024-2032³â 3.7%ÀÇ CAGRÀ» ±â·ÏÇÕ´Ï´Ù.

ÃÊÀ½ÆÄ ±â¼úÀÇ Çõ½ÅÀº À̹ÌÁöÀÇ °íÇØ»óµµÈ­, ÈÞ´ë¿ë ±â±â, Áø´Ü ±â´É °­È­ µî ÀÇ·á ¿µ»ó¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ½ÉÀåÇÐ, »êºÎÀΰú, Á¾¾çÇÐ µî ´Ù¾çÇÑ ÀÇ·á Àü¹® ºÐ¾ß¿¡ Àû¿ëµÇ¾î ÀÓ»óÀÇ¿¡°Ô º¸´Ù Á¤È®Çϰí È¿À²ÀûÀÎ Áø´Ü ÅøÀ» Á¦°øÇÕ´Ï´Ù.

¿¹¸¦ µé¾î 2024³â 7¿ù ³×ÀÌó(Nature)Áö¿¡ °ÔÀçµÈ ³í¹®¿¡¼­´Â ¿þ¾î·¯ºí ÃÊÀ½ÆÄ ±â¼úÀÌ »ý¸®Àû °úÁ¤ÀÇ ½Ç½Ã°£ ¸ð´ÏÅ͸µÀ» ÅëÇØ ÀǷḦ º¯È­½Ãų ¼ö ÀÖ´Â °¡´É¼º¿¡ ´ëÇÑ ¹Ì±¹ ¿¬±¸ÁøÀÇ ¿¬±¸ °á°ú°¡ ¼Ò°³µÇ¾ú½À´Ï´Ù. ¿þ¾î·¯ºí ÃÊÀ½ÆÄÀÇ °³¹ß¿¡´Â À¯È¿¼º, »ç¿ë ÆíÀǼº ¹× ½Å·Ú¼ºÀ» º¸ÀåÇϱâ À§ÇÑ ¸é¹ÐÇÑ ±â¼ú ´Ü°è°¡ ÀÖ¾ú½À´Ï´Ù. »ýü Á¢ÂøÁ¦¸¦ »ç¿ëÇÏ¿© ÇǺο¡ ´Ü´ÜÈ÷ ¹ÐÂøµÇ´Â ¼ÒÇü ÃÊÀ½ÆÄ ÇÁ·Îºê¸¦ ¼³°èÇϰí Á¦Á¶ÇÏ´Â °ÍºÎÅÍ ½ÃÀ۵Ǿú½À´Ï´Ù.

¶ÇÇÑ ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀº ÃÊÀ½ÆÄ À̹ÌÁö ºÐ¼®À» °­È­ÇÏ¿© ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ÀÇ·á±â±â Á¦Á¶¾÷üµéÀº ÁøÈ­ÇÏ´Â ÀÇ·á ¼ö¿ä¸¦ ÃæÁ·½Ãų ¼ö ÀÖ´Â Â÷¼¼´ë ÃÊÀ½ÆÄ ÇÁ·Îºê¸¦ µµÀÔÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀÌ ºñħ½ÀÀû Áø´Ü ¹æ¹ý°ú ȯÀÚ Áß½ÉÀÇ Ä¡·á¸¦ ¿ì¼±½ÃÇÔ¿¡ µû¶ó Çõ½ÅÀûÀÎ ÃÊÀ½ÆÄ ÇÁ·Îºê¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© Àü ¼¼°è¿¡¼­ ±â¼ú ¹ßÀü°ú Áø´Ü °á°úÀÇ °³¼±À» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º ºÐ¾ß´Â 2024-2032³â »çÀÌ¿¡ Ä¡¿­ÇÑ °³¹ßÀÌ ÀÌ·ç¾îÁú °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¿µ»ó ó¸®, ºÐ¼® ¹× ÇØ¼®À» Æ÷ÇÔÇÑ ÃÊÀ½ÆÄ ¿µ»ó ó¸® ±â´ÉÀ» Çâ»ó½Ãų °ÍÀÔ´Ï´Ù. ÷´Ü ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀ» ÅëÇØ ÀÓ»óÀÇ´Â º¸´Ù »ó¼¼Çϰí Á¤È®ÇÑ Áø´Ü Á¤º¸¸¦ »ý¼ºÇÒ ¼ö ÀÖÀ¸¸ç, ȯÀÚ Ä¡·á¿Í Ä¡·á °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿ø°ÝÀÇ·á ÅëÇÕ ¹× Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç°ú °°Àº ¼­ºñ½º °­È­´Â ¿ø°ÝÁö¿¡¼­ÀÇ ÃÊÀ½ÆÄ ¿µ»ó Áø´Ü ¹× µ¥ÀÌÅÍ °ü¸®¸¦ ¿ëÀÌÇÏ°Ô ÇÏ¿© ÀÇ·á ¼­ºñ½º Á¦°øÀÇ Á¢±Ù¼º°ú È¿À²¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀÌ ÀÓ»ó Áø·á¿¡ ±â¼úÀ» ¿øÈ°ÇÏ°Ô ÅëÇÕÇÏ´Â °ÍÀ» ¿ì¼±½ÃÇÏ´Â °¡¿îµ¥, ÷´Ü ¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º¸¦ °®Ãá ÃÊÀ½ÆÄ ÇÁ·Îºê¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖÀ¸¸ç, Àü ¼¼°è ÀÇ·á ÇöÀå¿¡¼­ Áø´Ü Á¤È®µµ¸¦ ³ôÀÌ°í ¿öÅ©Ç÷ο츦 ÃÖÀûÈ­ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù.

½ÉÀåÇ÷°ü ºÐ¾ßÀÇ ÃÊÀ½ÆÄ ÇÁ·Îºê ½ÃÀå ¸ÅÃâÀº 2024-2032³â ´«¿¡ ¶ç´Â CAGRÀ» ³ªÅ¸³¾ °ÍÀÔ´Ï´Ù. ÃÊÀ½ÆÄ ÇÁ·Îºê´Â ½ÉÀåÀÇ ±¸Á¶¿Í ±â´ÉÀ» Æò°¡ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ¸ç ½ÉÀå Áúȯ, ÆÇ¸· ÀÌ»ó, ¼±Ãµ¼º ±âÇü µîÀ» Áø´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÷´Ü ÇÁ·Îºê´Â ½ÉÃÊÀ½ÆÄ ¹× µµÇ÷¯ À̹Ì¡°ú °°Àº »ó¼¼ÇÑ À̹Ì¡ ±â´ÉÀ» Á¦°øÇÏ¿© Ç÷·ù ¹× ½ÉÀå ¼º´ÉÀ» Æò°¡ÇÏ´Â µ¥ ÇʼöÀûÀÎ ½ÉÃÊÀ½ÆÄ ¹× µµÇ÷¯ À̹Ì¡ ±â´ÉÀ» Á¦°øÇÕ´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀÌ ¿©ÀüÈ÷ Àü ¼¼°è »ç¸Á·üÀÇ ÁÖ¿ä ¿øÀÎÀ¸·Î ³²¾Æ ÀÖÀ¸¹Ç·Î ÃÊÀ½ÆÄ ÇÁ·Îºê ½ÃÀåÀº ½ÉÀå ÁúȯÀ» Á¶±â¿¡ ¹ß°ßÇϰí Á¤È®ÇÏ°Ô ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â È¿°úÀûÀÎ Áø´Ü Åø¿¡ ´ëÇÑ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õÀÇ ¿ä±¸¿¡ µû¶ó Áö¼ÓÀûÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù.

À¯·´ÀÇ ÃÊÀ½ÆÄ ÇÁ·Îºê ½ÃÀåÀº 2024-2032³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)ÀÌ µÎµå·¯Áú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÃÊÀ½ÆÄ ÇÁ·Îºê´Â »êºÎÀΰú, ½ÉÀåÇÐ, Á¾¾çÇÐ µî ´Ù¾çÇÑ ÀÇ·á ¿ëµµ¿¡ ÇʼöÀûÀÌ¸ç ½Ç½Ã°£ ¿µ»ó°ú Á¤È®ÇÑ Áø´Ü ±â´ÉÀ» Á¦°øÇÕ´Ï´Ù. ȯÀÚ °á°ú °³¼±°ú ÀÇ·á ¼­ºñ½º È¿À²¼º Çâ»ó¿¡ ÃÊÁ¡À» ¸ÂÃá À¯·´ÀÇ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀº ÷´Ü ÃÊÀ½ÆÄ ±â¼ú¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â ÈÞ´ë¿ë ÇÁ·Îºê, ÇÚµåÇïµå ÇÁ·Îºê, À̹ÌÁö ºÐ¼®À» °­È­Çϱâ À§ÇÑ Çõ½ÅÀûÀÎ ¼ÒÇÁÆ®¿þ¾î µîÀÌ Æ÷ÇԵ˴ϴÙ. ȯÀÚ ¾ÈÀü°ú Áø´ÜÀÇ Á¤È®¼ºÀ» °­Á¶ÇÏ´Â ±ÔÁ¦ ±âÁØÀÇ °­È­·Î À¯·´³» ÃÊÀ½ÆÄ ÇÁ·Îºê¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â À¯·´ Àü¿ªÀÇ Á¾ÇÕÀûÀÎ ÀÇ·á ¼­ºñ½º Á¦°øÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • ¿¡ÄڽýºÅÛ ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ÃËÁø¿äÀÎ
      • ¸¸¼ºÁúȯÀÇ Áõ°¡
      • POC(Point of Care)¿¡¼­ ¾ÖÇø®ÄÉÀ̼ÇÀÇ È®´ë
      • ÃÊÀ½ÆÄ ÇÁ·ÎºêÀÇ ±â¼ú Áøº¸
      • ÇコÄɾî ÁöÃâÀÇ Áõ°¡
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ© & °úÁ¦
      • ±â±âÀÇ °íºñ¿ë
      • ¾ö°ÝÇÑ ±ÔÁ¦ ½Ã³ª¸®¿À
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±â¼úÀû Àü¸Á
  • ±ÔÁ¦ »óȲ
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« Àü¸Á ¸ÅÆ®¸¯½º

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Á¦Ç°º°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ÇÁ·Îºê
    • ¼±Çü ÇÁ·Îºê
    • Äܺ¤½º ÇÁ·Îºê
    • À§»ó ¹è¿­/½ÉÀå ÇÁ·Îºê
    • °æ½Äµµ(TEE) ÇÁ·Îºê
    • ³»°­ ÇÁ·Îºê
    • ³úÇ÷°ü ÇÁ·Îºê
    • ±âŸ ÇÁ·Îºê
  • ¼ÒÇÁÆ®¿þ¾î & ¼­ºñ½º
  • ¾×¼¼¼­¸®

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¿ëµµº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ±Ù°ñ°Ý°è
  • Á¾¾ç
  • ¼øÈ¯±â
  • »ê°ú¡¤ºÎÀΰú
  • ÀÏ¹Ý ¿µ»ó Áø´Ü
  • ±âŸ ¿ëµµ

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø ¹× Áø·á¼Ò
  • Áø´Ü ¼¾ÅÍ
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ °³¿ä

  • Canon Inc.
  • Esaote SPA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Koninklijke Philips NV
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Samsung Electronics Co., Ltd.
  • Siemens Healthineers AG
  • SonoScape Medical Corp
  • Terason Division Teratech Corporation
KSA 24.08.14

Global Ultrasound Probes Market will witness 3.7% CAGR between 2024 and 2032, driven by continuous innovations and advanced product launches. Innovations in ultrasound technology, such as higher image resolution, portable devices, and enhanced diagnostic capabilities, are revolutionizing medical imaging. These advancements cater to diverse medical specialties, including cardiology, obstetrics, and oncology, offering clinicians more accurate and efficient diagnostic tools.

For instance, in July 2024, an article in Nature showcased American researchers' findings on wearable ultrasound technology's potential to transform healthcare through real-time monitoring of physiological processes. The development of wearable ultrasound involved meticulous technical stages to ensure effectiveness, ease of use, and dependability. It commenced with designing and producing compact ultrasound probes that securely adhere to the skin using bioadhesives.

Additionally, the integration of artificial intelligence and machine learning is enhancing ultrasound image analysis, further boosting market growth. Leading medical device companies are investing in research and development to introduce next-generation ultrasound probes that meet evolving healthcare needs. As healthcare providers prioritize non-invasive diagnostic methods and patient-centric care, the demand for innovative ultrasound probes is expected to grow, driving technological advancements and improving diagnostic outcomes globally.

The overall Ultrasound Probes Industry size is classified based on the product, application, end-use, and region.

The software and services segment will undergo rigorous development from 2024 to 2032. These innovations enhance ultrasound imaging capabilities, including image processing, analysis, and interpretation. Advanced software solutions enable clinicians to generate more detailed and accurate diagnostic information, improving patient care and treatment outcomes. Additionally, service enhancements such as telemedicine integration and cloud-based solutions facilitate remote ultrasound imaging and data management, expanding accessibility and efficiency in healthcare delivery. As healthcare providers prioritize seamless integration of technology into clinical practice, the demand for ultrasound probes equipped with sophisticated software and services continues to grow, supporting enhanced diagnostic accuracy and workflow optimization in medical settings globally.

The ultrasound probes market revenue from the cardiovascular segment will register a notable CAGR from 2024 to 2032. Ultrasound probes play a crucial role in assessing heart structure and function, aiding in the diagnosis of conditions like heart disease, valve abnormalities, and congenital defects. Advanced probes offer detailed imaging capabilities, including echocardiography and Doppler imaging, essential for evaluating blood flow and cardiac performance. As cardiovascular diseases remain a leading cause of morbidity worldwide, the market for ultrasound probes continues to expand, driven by healthcare providers' need for effective diagnostic tools that enable early detection and precise monitoring of cardiac conditions.

Europe ultrasound probes market from Europe will showcase a commendable CAGR from 2024 to 2032. Ultrasound probes are essential for various medical applications, including obstetrics, cardiology, and oncology, offering real-time imaging and precise diagnostic capabilities. With a focus on improving patient outcomes and enhancing healthcare efficiency, European healthcare providers are investing in advanced ultrasound technologies. These include portable and handheld probes, as well as software innovations for enhanced image analysis. As regulatory standards emphasize patient safety and diagnostic accuracy, the demand for ultrasound probes in Europe continues to grow, supporting comprehensive healthcare delivery across the continent.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Expanding applications in point-of-care settings
      • 3.2.1.3 Technological advancement in ultrasound probes
      • 3.2.1.4 Rising healthcare expenditure
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of equipment
      • 3.2.2.2 Stringent regulatory scenario
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Probe
    • 5.2.1 Linear probe
    • 5.2.2 Convex probe
    • 5.2.3 Phased array/cardiac probe
    • 5.2.4 Transesophageal (TEE) probe
    • 5.2.5 Endocavitary probe
    • 5.2.6 Cerebrovascular doppler
    • 5.2.7 Other probes
  • 5.3 Software & services
  • 5.4 Accessories

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Musculoskeletal
  • 6.3 Oncology
  • 6.4 Cardiovascular
  • 6.5 Obstetrics & gynecology
  • 6.6 General imaging
  • 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals and clinics
  • 7.3 Diagnostic centers
  • 7.4 Ambulatory surgical centers
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Canon Inc.
  • 9.2 Esaote SPA
  • 9.3 Fujifilm Holdings Corporation
  • 9.4 GE HealthCare Technologies Inc.
  • 9.5 Hitachi, Ltd.
  • 9.6 Koninklijke Philips NV
  • 9.7 Mindray Bio-Medical Electronics Co., Ltd.
  • 9.8 Samsung Electronics Co., Ltd.
  • 9.9 Siemens Healthineers AG
  • 9.10 SonoScape Medical Corp
  • 9.11 Terason Division Teratech Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦